Erisyon
PrivateLast Round
Grant
Jan 7, 2025
Total Funding Raised
$3.08M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Erisyon Inc. is a biotechnology company that is commercializing a single-molecule protein sequencing platform to detect, treat, and track disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS, Government Contracts, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Erisyon Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Erisyon Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 7, 2025 | ||||
| Grant | Sep 22, 2022 | ||||
| Seed | Nov 30, 2020 | ||||
| Grant | Jun 1, 2020 | ||||
| Grant | May 14, 2020 |
Key People
Founding team and executive leadership
Erisyon Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| Research Bridge Partners | Seed |
| Cancer Prevention and Research Institute of Texas | Grant |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 22, 2026
Monthly visitors increased 148% MoM, reaching 1.4K.
- May 4, 2025
Monthly visitors grew 580% MoM, reaching 1.4K.
Erisyon Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Erisyon's valuation, stock price, and market status.